{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:05:39Z","timestamp":1768399539481,"version":"3.49.0"},"reference-count":29,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2014]]},"DOI":"10.7883\/yoken.67.288","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T10:11:02Z","timestamp":1406196662000},"page":"288-291","source":"Crossref","is-referenced-by-count":11,"title":["Antibiotic Susceptibility of Neisseria gonorrhoeae Isolates from Guangzhou, China, during 2002\u20132011"],"prefix":"10.7883","volume":"67","author":[{"given":"Heping","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingzhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaohua","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyuan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanmei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangli","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant <i>Neisseria gonorrhoeae<\/i>. Expert Rev Anti Infect Ther. 2009;7:821-34.","DOI":"10.1586\/eri.09.63"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in <i>Neisseria gonorrhoeae<\/i>: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148:606-13.","DOI":"10.7326\/0003-4819-148-8-200804150-00005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tapsall J. Antibiotic resistance in <i>Neisseria gonorrhoeae<\/i> is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther. 2006;4:619-28.","DOI":"10.1586\/14787210.4.4.619"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yokoi S, Deguchi T, Ozawa T, et al. Treat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13:1275-7.","DOI":"10.3201\/eid1308.060948"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England. Euro Surveill. 2001;16:pii=19833.","DOI":"10.2807\/ese.16.14.19833-en"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first line cefixime for gonorrhoea treatment, Norway. Euro Surveill. 2010;15:pii=19721.","DOI":"10.2807\/ese.15.47.19721-en"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. C&aacute;mara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant <i>Neisseria gonorrhoeae<\/i> isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012;67:1858-60.","DOI":"10.1093\/jac\/dks162"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant <i>Neisseria gonorrhoeae<\/i> in France: novel <i>penA<\/i> mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273-80.","DOI":"10.1128\/AAC.05760-11"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone-resistant <i>Neisseria gonorrhoeae<\/i>, Japan. Emerg Infect Dis. 2011;17:148-9.","DOI":"10.3201\/eid1701.100397"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zheng HP, Cao WL, Wu XZ, et al. Antimicrobial susceptibility of <i>Neisseria gonorrhoeae<\/i> strains isolated in Guangzhou, China, 1996&ndash;2001. Sex Transm Infect. 2003;79:399-402.","DOI":"10.1136\/sti.79.5.399"},{"key":"11","unstructured":"11. Wu XZ, Zheng HP, Li YW, et al. In vitro susceptibility to six antimicrobial agents and the resistance plasmids genotype of <i>Neisseria gorrhoeae<\/i> isolates from four cities in Guangdong. J Diagn Ther Dermato&ndash;Venereol. 2012;19:352-5 (in Chinese)."},{"key":"12","unstructured":"12. NCSTD: Epidemiologic Reports of Syphilis and Gonorrheae Case Reports in China. [http:\/\/www.ncstdc.org\/upfiles\/201303\/20130319152506703.pdf], accessed on 2012, 1 (in Chinese)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lau JT, Kim JH, Lau M, et al. Prevalence and risk behaviors of Hong Kong males who seek cross-border same-sex partners in mainland China. Sex Transm Dis. 2004;31:568-74.","DOI":"10.1097\/01.olq.0000137905.94154.0a"},{"key":"14","unstructured":"14. World Health Organization (WHO). Sensitivity testing of <i>Neisseria gonorrhoeae<\/i>: Methodologies for use by participants in the WHO Western Pacific regional surveillance programme. In: WHO\/WPRO Regional Antimicrobial Surevillance Working Group Meeting Proceedings. 1992;33-4."},{"key":"15","unstructured":"15. Chevalier B, Crenn Y, Cavallo JD, et al. Comparative activity of azithromycin against 100 strains of <i>Neisseria gonorrhoeae<\/i>. Pathol Biol (Paris). 1995;43:281-3."},{"key":"16","unstructured":"16. Van Dyck E, Piot P, Meheus A. Bench-level laboratory manual for sexually transmitted diseases, VDT\/89.443. Geneva: World Health Organization (WHO). 1989."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in <i>Neisseria gonorrhoeae<\/i> in Nanjing, China, 1999-2006. Sex Transm Dis. 2007;34:995-9.","DOI":"10.1097\/OLQ.0b013e3180ca8f24"},{"key":"18","unstructured":"18. Gu WM, Yang Y, Wu l. Surveillance on antibiotic susceptibility of <i>Neisseria gonorrhoeae<\/i> from 1988 to 2002 in Shanghai. Chin J Dermatol. 2004;37:323-5 (in Chinese)."},{"key":"19","unstructured":"19. Zhou X, Liu X, Zhang Z. Analysis of drug-resistance of <i>Neisseria gonorrhoeae<\/i> to antibiotics in Dalian from 2009-2011. China Health Care & Nutrition. 2013;1:388-9 (in Chinese)."},{"key":"20","unstructured":"20. Zhong N, Zheng W, Wang F, et al. Analysis on the drug-resistance of <i>Nersseria gonorrhoeae<\/i> to Antibiotics in Hainan area from 2006-2011. Chin J Derm Venereol. 2013;27:56-7 (in Chinese)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jabeen K, Nizamuddin S, Irfan S, et al. Increasing trend of resistance to penicillin, tetracycline, and fluoroquinolone resistance in <i>Neisseria gonorrhoeae<\/i> from Pakistan (1992&ndash;2009). J Trop Med, 2011; 960501. doi: 10.1155\/2011\/960501.","DOI":"10.1155\/2011\/960501"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Olsen B, Pham TL, Golparian D, et al. Antimicrobial susceptibility and genetic characteristics of <i>Neisseria gonorrhoeae<\/i> isolates from Vietnam, 2011. BMC Infect Dis. 2013;doi:10.1186\/1471-2334-13-40.","DOI":"10.1186\/1471-2334-13-40"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sethi S, Golparian D, Bala M, et al. Antimicrobial susceptibility and genetic characteristics of <i>Neisseria gonorrhoeae<\/i> isolates from India, Pakistan and Bhutan in 2007&ndash;2011. BMC Infect Dis. 2013;doi:10.1186\/1471-2334-13-35.","DOI":"10.1186\/1471-2334-13-35"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009;10:555-77.","DOI":"10.1517\/14656560902731993"},{"key":"25","unstructured":"25. Kirkcaldy RD, Ballard RC, Dowell D. Gonococcal resistance: are cephalosporins next? Curr Infect Dis Rep. 2011;13:196-204."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant <i>Neisseria gonorrhoeae<\/i>. Exp Rev Anti Infect Ther. 2009;7:821-34.","DOI":"10.1586\/eri.09.63"},{"key":"27","unstructured":"27. Centers for Disease Control and Prevention. Cephalosporin susceptibility among <i>Neisseria gonorrhoeae<\/i> isolates&ndash;United States, 2000&ndash;2010. MMWR Morb Mortal Wkly Rep. 2011;60:873-7."},{"key":"28","unstructured":"28. Australian Gonococcal Surveillance Programme, Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2008. Commun Dis Intell Q Rep. 2009;33:268-74."},{"key":"29","unstructured":"29. Yan H, Yin YP, Dai XQ. Antimicrobial resistance in clinical isolates of <i>Neisseria gonorrhoeae<\/i> in China, 2008:an epidemiological study. Chin J Dermatol. 2011;44:472-5 (in Chinese)."}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T22:43:44Z","timestamp":1746312224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/67\/4\/67_288\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.67.288","relation":{},"ISSN":["1344-6304"],"issn-type":[{"value":"1344-6304","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}